Cargando…
Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation
BACKGROUND: At present, colorectal cancer is routinely treated with adjuvant radiotherapy and chemotherapy postoperatively. The adverse effects (AEs) of chemotherapy usually interrupt the treatment of chemotherapy. Traditional Chinese medicine (TCM) has demonstrated great potential in improving pati...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610922/ https://www.ncbi.nlm.nih.gov/pubmed/34877325 http://dx.doi.org/10.12998/wjcc.v9.i32.9869 |
_version_ | 1784603193565511680 |
---|---|
author | Li, Zheng Yin, Dong-Feng Wang, Wei Zhang, Xin-Wei Zhou, Li-Jiang Yang, Jun |
author_facet | Li, Zheng Yin, Dong-Feng Wang, Wei Zhang, Xin-Wei Zhou, Li-Jiang Yang, Jun |
author_sort | Li, Zheng |
collection | PubMed |
description | BACKGROUND: At present, colorectal cancer is routinely treated with adjuvant radiotherapy and chemotherapy postoperatively. The adverse effects (AEs) of chemotherapy usually interrupt the treatment of chemotherapy. Traditional Chinese medicine (TCM) has demonstrated great potential in improving patients' clinical symptoms, regulating the immune function, improving the life quality, and reducing the AEs of chemotherapy. AIM: To observe the clinical efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation. METHODS: Data from patients diagnosed with colorectal cancer between January 2019 and February 2021 were collected from Liaoning Cancer Hospital and Institute and the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Patients receiving the chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) after radical resection of colorectal cancer were prospectively collected and randomly divided into an experimental group and a control group. The experimental group was given Yiqi Jianpi anti-cancer prescription combined with the CAPOX regimen, while the control group was given the CAPOX regimen alone. After six cycles of chemotherapy, the scores of TCM symptoms, Karnofsky performance scale (KPS) score, levels of T-cell subsets, and AEs after chemotherapy of the two groups were compared. RESULTS: A total of 70 patients were randomly divided into either an experimental group (n = 35, no dropout) or a control group (n = 33, with 2 dropouts). Compared with the control group, the experimental group improved significantly (P < 0.05) in scores of TCM symptoms, KPS score, levels of T-cell subsets, and AEs of chemotherapy. CONCLUSION: Yiqi Jianpi anti-cancer prescription can effectively improve spleen deficiency, regulate the immune function, and alleviate the AEs of chemotherapy, so as to improve the life quality of patients with good therapeutic effects and application prospect in clinical practice. |
format | Online Article Text |
id | pubmed-8610922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-86109222021-12-06 Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation Li, Zheng Yin, Dong-Feng Wang, Wei Zhang, Xin-Wei Zhou, Li-Jiang Yang, Jun World J Clin Cases Prospective Study BACKGROUND: At present, colorectal cancer is routinely treated with adjuvant radiotherapy and chemotherapy postoperatively. The adverse effects (AEs) of chemotherapy usually interrupt the treatment of chemotherapy. Traditional Chinese medicine (TCM) has demonstrated great potential in improving patients' clinical symptoms, regulating the immune function, improving the life quality, and reducing the AEs of chemotherapy. AIM: To observe the clinical efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation. METHODS: Data from patients diagnosed with colorectal cancer between January 2019 and February 2021 were collected from Liaoning Cancer Hospital and Institute and the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Patients receiving the chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) after radical resection of colorectal cancer were prospectively collected and randomly divided into an experimental group and a control group. The experimental group was given Yiqi Jianpi anti-cancer prescription combined with the CAPOX regimen, while the control group was given the CAPOX regimen alone. After six cycles of chemotherapy, the scores of TCM symptoms, Karnofsky performance scale (KPS) score, levels of T-cell subsets, and AEs after chemotherapy of the two groups were compared. RESULTS: A total of 70 patients were randomly divided into either an experimental group (n = 35, no dropout) or a control group (n = 33, with 2 dropouts). Compared with the control group, the experimental group improved significantly (P < 0.05) in scores of TCM symptoms, KPS score, levels of T-cell subsets, and AEs of chemotherapy. CONCLUSION: Yiqi Jianpi anti-cancer prescription can effectively improve spleen deficiency, regulate the immune function, and alleviate the AEs of chemotherapy, so as to improve the life quality of patients with good therapeutic effects and application prospect in clinical practice. Baishideng Publishing Group Inc 2021-11-16 2021-11-16 /pmc/articles/PMC8610922/ /pubmed/34877325 http://dx.doi.org/10.12998/wjcc.v9.i32.9869 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Prospective Study Li, Zheng Yin, Dong-Feng Wang, Wei Zhang, Xin-Wei Zhou, Li-Jiang Yang, Jun Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation |
title | Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation |
title_full | Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation |
title_fullStr | Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation |
title_full_unstemmed | Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation |
title_short | Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation |
title_sort | efficacy of yiqi jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation |
topic | Prospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610922/ https://www.ncbi.nlm.nih.gov/pubmed/34877325 http://dx.doi.org/10.12998/wjcc.v9.i32.9869 |
work_keys_str_mv | AT lizheng efficacyofyiqijianpianticancerprescriptioncombinedwithchemotherapyinpatientswithcolorectalcancerafteroperation AT yindongfeng efficacyofyiqijianpianticancerprescriptioncombinedwithchemotherapyinpatientswithcolorectalcancerafteroperation AT wangwei efficacyofyiqijianpianticancerprescriptioncombinedwithchemotherapyinpatientswithcolorectalcancerafteroperation AT zhangxinwei efficacyofyiqijianpianticancerprescriptioncombinedwithchemotherapyinpatientswithcolorectalcancerafteroperation AT zhoulijiang efficacyofyiqijianpianticancerprescriptioncombinedwithchemotherapyinpatientswithcolorectalcancerafteroperation AT yangjun efficacyofyiqijianpianticancerprescriptioncombinedwithchemotherapyinpatientswithcolorectalcancerafteroperation |